Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14WL9 | ISIN: FR0011051598 | Ticker-Symbol: A1H
Frankfurt
13.05.26 | 09:08
0,887 Euro
-1,11 % -0,010
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
AMOEBA Chart 1 Jahr
5-Tage-Chart
AMOEBA 5-Tage-Chart
RealtimeGeldBriefZeit
0,9060,97620:45

Aktuelle News zur AMOEBA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SaBrain-Eating Amoeba Found in Lake Mead Near Las Vegas2
06.05.AMOEBA: Two new exceptional trial permits in the Netherlands in 2026 for Amoéba's biocontrol solution874Amoéba and Koppert have each been granted special authorization to use AXPERA technology on a wide range of crops These exemptions include food crops for consumption. Chassieu (France), 6...
► Artikel lesen
28.04.AMOEBA: Amoéba has obtained a new emergency authorization for the use of the AXPERA biocontrol solution to protect French vineyards496Chassieu (France), 28 April 2026 - 6:00 p.m. - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has received...
► Artikel lesen
AMOEBA Aktie jetzt für 0€ handeln
13.04.AMOEBA: Amoéba and Koppert highlight the potential of AXPERA technology in Brazil for strategic crops396Chassieu (France), 13 April 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of...
► Artikel lesen
26.03.AMOEBA: Amoéba announces the success of its capital increase and raises EUR 6.67 million906Chassieu (France), 26 March 2026 - 8:00 a.m. - Amoéba (FR0011051598 - ALMIB ), an industrial greentech specialized in the development of natural microbiological solutions based on the patented...
► Artikel lesen
25.03.AMOEBA: Amoéba strengthens its financial visibility to support its industrial and commercial expansion1.413Press release This press release must not be released, published or distributed, directly or indirectly, within or to the United States of America, Canada, Australia or Japan. This press...
► Artikel lesen
19.03.Amoeba - Preparing for commercialisation in 2026438Amoéba's FY25 was marked by regulatory and pre-commercial progress across biocontrol and cosmetics, alongside higher industrial deployment spend ahead of a planned move into commercialisation in 2026....
► Artikel lesen
19.03.AMOEBA: Amoéba: Ordinary and Extraordinary General Meeting of 3 April 2026616Chassieu (France), 19 March 2026 - 8:45 am - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of...
► Artikel lesen
18.03.AMOEBA: Amoéba announces the publication of its Universal Registration Document 2025464Chassieu (France), 18 March 2026 - 6 p.m. - Amoéba (FR0011051598 - ALMIB), an industrial greentech specialized in the development of natural microbiological solutions based on the patented use...
► Artikel lesen
11.03.AMOEBA: Amoéba receives its first order from Koppert and confirms its transformation into a commercial company572Press release Chassieu (France), 11 March 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based...
► Artikel lesen
23.02.AMOEBA: Amoéba: final phase for marketing authorisation of AXPERA520The ANSES evaluation process for the application submitted in March 2025 is currently in its final stage. At the same time, French and Italian agricultural sectors have begun procedures to obtain...
► Artikel lesen
23.02.AMOEBA: 2025 annual results: major regulatory and commercial advances paving the way for commercialisation in 2026515Chassieu (France), 23 February 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use...
► Artikel lesen
20.01.Amoeba: Gold medal winner at SIVAL, Amoéba displays its ambitions for its biocontrol solution751Chassieu, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Chassieu (France), 20 January 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological...
► Artikel lesen
20.01.AMOEBA: Gold medal winner at SIVAL, Amoéba displays its ambitions for its biocontrol solution661Chassieu (France), 20 January 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use...
► Artikel lesen
18.12.25AMOEBA: AXPERA wins the SIVAL d'Or Award: further recognising of the effectiveness of Amoéba's biocontrol solution679Official award ceremony: Wednesday, 14 January 2026, starting at 7 p.m. Innovation Area of the Grand Palais exhibition centre Angers Exhibition Centre (France) Chassieu (France), 18 December 2025...
► Artikel lesen
18.11.25AMOEBA: A natural breakthrough in protecting cereals and field crops // Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UK601Media Release Basel, Switzerland and Chassieu, France, 11/18/2025 Amoebas. These single-celled microorganisms are now at the heart of one of agriculture's latest biological innovation...
► Artikel lesen
18.11.25Amoeba: A natural breakthrough in protecting cereals and field crops538Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UKChassieu, France Basel, Switzerland , Nov. 18, 2025 (GLOBE NEWSWIRE) -- Amoebas. These single-celled microorganisms...
► Artikel lesen
29.10.25AMOEBA: Amoéba presents the 2025 results of its vineyard trial campaign: AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use538Chassieu (France), 29 October 2025 - 08:00 am - Amoéba (FR0011051598 - ALMIB), an industrial greentech specialized in the development of natural microbiological solutions based on the patented...
► Artikel lesen
24.10.25AMOEBA: Amoéba: Publication of the half-year financial report as of June 30, 2025597Chassieu (France), October 24, 2025 - 6:00 p.m - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions based on the patented use...
► Artikel lesen
20.10.25AMOEBA: AXPERA named biocontrol solution of the year 2025 // Amoeba's anti-fungal innovation wins the Gold Award at the 2025 Bernard Blum Awards1.289Chassieu (France), 20 October 2025 - 6:30 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions based on the patented use...
► Artikel lesen
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1